☰

Maximilien Tailler - Publications

Affiliations: 
University Paris 11 
Area:
Apoptosis, Myelodysplastic syndromes, Acute myeloid leukemia, Screening
Tree Info Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Chappaz S, McArthur K, Kealy L, Law CW, Tailler M, Lane RM, Lieschke A, Ritchie ME, Good-Jacobson KL, Strasser A, Kile BT. Homeostatic apoptosis prevents competition-induced atrophy in follicular B cells. Cell Reports. 36: 109430. PMID 34289356 DOI: 10.1016/j.celrep.2021.109430  0.391
2020 Balka KR, Louis C, Saunders TL, Smith AM, Calleja DJ, D'Silva DB, Moghaddas F, Tailler M, Lawlor KE, Zhan Y, Burns CJ, Wicks IP, Miner JJ, Kile BT, Masters SL, et al. TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells. Cell Reports. 31: 107492. PMID 32268090 DOI: 10.1016/j.celrep.2020.03.056  0.31
2018 Tailler M, Lindqvist LM, Gibson L, Adams JM. By reducing global mRNA translation in several ways, 2-deoxyglucose lowers MCL-1 protein and sensitizes hemopoietic tumor cells to BH3 mimetic ABT737. Cell Death and Differentiation. PMID 30538285 DOI: 10.1038/S41418-018-0244-Y  0.333
2015 Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis : An International Journal On Programmed Cell Death. 20: 1666-7. PMID 26400497 DOI: 10.1007/S10495-015-1154-9  0.796
2013 Sandow JJ, Dorstyn L, O'Reilly LA, Tailler M, Kumar S, Strasser A, Ekert PG. ER stress does not cause upregulation and activation of caspase-2 to initiate apoptosis. Cell Death and Differentiation. 21: 475-80. PMID 24292555 DOI: 10.1038/cdd.2013.168  0.32
2012 Senovilla L, Vitale I, Martins I, Tailler M, Pailleret C, Michaud M, Galluzzi L, Adjemian S, Kepp O, Niso-Santano M, Shen S, Mariño G, Criollo A, Boilève A, Job B, et al. An immunosurveillance mechanism controls cancer cell ploidy. Science (New York, N.Y.). 337: 1678-84. PMID 23019653 DOI: 10.1126/Science.1224922  0.786
2012 Galluzzi L, Vitale I, Senovilla L, Olaussen KA, Pinna G, Eisenberg T, Goubar A, Martins I, Michels J, Kratassiouk G, Carmona-Gutierrez D, Scoazec M, Vacchelli E, Schlemmer F, Kepp O, ... ... Tailler M, et al. Prognostic impact of vitamin B6 metabolism in lung cancer. Cell Reports. 2: 257-69. PMID 22854025 DOI: 10.1016/J.Celrep.2012.06.017  0.714
2012 Jemaà M, Vitale I, Kepp O, Berardinelli F, Galluzzi L, Senovilla L, Mariño G, Malik SA, Rello-Varona S, Lissa D, Antoccia A, Tailler M, Schlemmer F, Harper F, Pierron G, et al. Selective killing of p53-deficient cancer cells by SP600125. Embo Molecular Medicine. 4: 500-14. PMID 22438244 DOI: 10.1002/Emmm.201200228  0.763
2011 Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, Shen S, Kepp O, Scoazec M, Mignot G, Rello-Varona S, Tailler M, Menger L, Vacchelli E, Galluzzi L, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (New York, N.Y.). 334: 1573-7. PMID 22174255 DOI: 10.1126/Science.1208347  0.752
2011 Tailler M, Senovilla L, Lainey E, Thépot S, Métivier D, Sébert M, Baud V, Billot K, Fenaux P, Galluzzi L, Boehrer S, Kroemer G, Kepp O. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene. 31: 3536-46. PMID 22105358 DOI: 10.1038/Onc.2011.521  0.788
2011 Boehrer S, Galluzzi L, Lainey E, Bouteloup C, Tailler M, Harper F, Pierron G, Adès L, Thépot S, Sébert M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib antagonizes constitutive activation of SRC family kinases and mTOR in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 3168-75. PMID 21897118 DOI: 10.4161/Cc.10.18.16599  0.782
2011 Lainey E, Thépot S, Bouteloup C, Sébert M, Adès L, Tailler M, Gardin C, de Botton S, Baruchel A, Fenaux P, Kroemer G, Boehrer S. Tyrosine kinase inhibitors for the treatment of acute myeloid leukemia: delineation of anti-leukemic mechanisms of action. Biochemical Pharmacology. 82: 1457-66. PMID 21664897 DOI: 10.1016/J.Bcp.2011.05.011  0.734
2011 Thépot S, Lainey E, Cluzeau T, Sébert M, Leroy C, Adès L, Tailler M, Galluzzi L, Baran-Marszak F, Roudot H, Eclache V, Gardin C, de Botton S, Auberger P, Fenaux P, et al. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia. Cell Cycle (Georgetown, Tex.). 10: 2323-30. PMID 21654193 DOI: 10.4161/Cc.10.14.16399  0.783
2011 BenYounès A, Tajeddine N, Tailler M, Malik SA, Shen S, Métivier D, Kepp O, Vitale I, Maiuri MC, Kroemer G. A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1. Autophagy. 7: 883-91. PMID 21460612 DOI: 10.4161/Auto.7.8.15538  0.71
2011 Sebert M, Lainey E, Lepelley P, Thepot S, Tailler M, Gardin C, Kroemer G, Boehrer S, Ades L, Fenaux P. Expression and Function of the P-Glycoprotein (P-gp) In Myelodysplastic Syndromes (MDS) Treated with Azacytidine (AZA) Blood. 118: 5028-5028. DOI: 10.1182/Blood.V118.21.5028.5028  0.67
2011 Lainey E, Sebert M, Bouteloup C, Leroy C, Thepot S, Tailler M, Ades L, Gardin C, Kroemer G, Fenaux P, Boehrer S. Potentiation of Apoptosis in MDS/AML by Combination of Azacitidine and the EGFR-Tyrosine Kinase Inhibitor (TKI) erlotinib Blood. 118: 2790-2790. DOI: 10.1182/Blood.V118.21.2790.2790  0.758
2011 Lainey E, Sebert M, Bouteloup C, Leroy C, Thepot S, Tailler M, Ades L, Gardin C, Kroemer G, Fenaux P, Boehrer S. Erlotinib Antagonizes Efflux Via ABC Transporters and Decreases P-Gp Cell Surface Expression by Inhibiting SRC Kinase and mTOR Pathways in Acute Myeloid Leukemia (AML) Blood. 118: 2564-2564. DOI: 10.1182/Blood.V118.21.2564.2564  0.728
2011 Thepot S, Lainey E, Sebert M, Tailler M, Leroy C, Bouteloup C, Ades L, Gardin C, Fenaux P, Kroemer G, Boehrer S. 189 Hypomethylating agents induce apoptosis and cell cycle arrest with a concomitant activation of p53-dependent signalling pathways and Foxo3a activation Leukemia Research. 35: S74-S75. DOI: 10.1016/S0145-2126(11)70191-6  0.756
2011 Sebert M, Elodie L, Thepot S, Tailler M, Leroy C, Bouteloup C, Ades L, Gardin C, Fenaux P, Boehrer S. 188 The EGFR-inhibitor erlotinib sensitizes MDS derived cells to chemotherapeutic agents by increasing their intracellular retention via modulation of ABC-transporters Leukemia Research. 35: S74. DOI: 10.1016/S0145-2126(11)70190-4  0.373
2011 Elodie L, Sebert M, Thepot S, Tailler M, Bouteloup C, Leroy C, Ades L, Fenaux P, Boehrer S. 165 Synergistic effects on apoptosis in higher risk MDS by combining azacitidine (AZA) and the EGFR-tyrosine kinase inhibitor erlotinib Leukemia Research. 35: S64-S65. DOI: 10.1016/S0145-2126(11)70167-9  0.387
2010 Martins I, Kepp O, Schlemmer F, Adjemian S, Tailler M, Shen S, Michaud M, Menger L, Gdoura A, Tajeddine N, Tesniere A, Zitvogel L, Kroemer G. Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress. Oncogene. 30: 1147-58. PMID 21151176 DOI: 10.1038/Onc.2010.500  0.743
2010 Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. IKK connects autophagy to major stress pathways. Autophagy. 6: 189-91. PMID 20110771 DOI: 10.4161/Auto.6.1.10818  0.778
2010 Criollo A, Senovilla L, Authier H, Maiuri MC, Morselli E, Vitale I, Kepp O, Tasdemir E, Galluzzi L, Shen S, Tailler M, Delahaye N, Tesniere A, De Stefano D, Younes AB, et al. The IKK complex contributes to the induction of autophagy. The Embo Journal. 29: 619-31. PMID 19959994 DOI: 10.1038/Emboj.2009.364  0.788
2010 Lainey E, Sebert M, Thepot S, Tailler M, Ades L, Gardin C, Kroemer G, Fenaux P, Boehrer S. Erlotinib Increases Efficacy of 5-Azacitidine (AZA) by Inhibiting Drug Efflux Via ABC-Transporters Blood. 116: 974-974. DOI: 10.1182/Blood.V116.21.974.974  0.758
2010 Sebert M, Lainey E, Thepot S, Tailler M, Ades L, Gardin C, Fenaux P, Kroemer G, Boehrer S. Erlotinib Inhibits ABC Transporters of AML Progenitors with Stem Cell Features and Increases Chemosensitivity to Current AML Drugs Blood. 116: 2163-2163. DOI: 10.1182/Blood.V116.21.2163.2163  0.699
2009 Olaussen KA, Commo F, Tailler M, Lacroix L, Vitale I, Raza SQ, Richon C, Dessen P, Lazar V, Soria JC, Kroemer G. Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines. Oncogene. 28: 4249-60. PMID 19749798 DOI: 10.1038/Onc.2009.277  0.571
2009 Boehrer S, Adès L, Tajeddine N, Hofmann WK, Kriener S, Bug G, Ottmann OG, Ruthardt M, Galluzzi L, Fouassier C, Tailler M, Olaussen KA, Gardin C, Eclache V, de Botton S, et al. Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome. Oncogene. 28: 2205-18. PMID 19398952 DOI: 10.1038/Onc.2009.69  0.647
2009 Vicencio JM, Ortiz C, Criollo A, Jones AW, Kepp O, Galluzzi L, Joza N, Vitale I, Morselli E, Tailler M, Castedo M, Maiuri MC, Molgó J, Szabadkai G, Lavandero S, et al. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1. Cell Death and Differentiation. 16: 1006-17. PMID 19325567 DOI: 10.1038/Cdd.2009.34  0.509
2008 Grosjean-Raillard J, Tailler M, Adès L, Perfettini JL, Fabre C, Braun T, De Botton S, Fenaux P, Kroemer G. ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene. 28: 1099-109. PMID 19079347 DOI: 10.1038/Onc.2008.457  0.775
2008 Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Flt3 receptor inhibition reduces constitutive NFkappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis : An International Journal On Programmed Cell Death. 13: 1148-61. PMID 18670883 DOI: 10.1007/s10495-008-0243-4  0.796
2008 Fabre C, Grosjean J, Tailler M, Boehrer S, Adès L, Perfettini JL, de Botton S, Fenaux P, Kroemer G. A novel effect of DNA methyltransferase and histone deacetylase inhibitors: NFkappaB inhibition in malignant myeloblasts. Cell Cycle (Georgetown, Tex.). 7: 2139-45. PMID 18641459 DOI: 10.4161/Cc.7.14.6268  0.757
2008 Boehrer S, Adès L, Galluzzi L, Tajeddine N, Tailler M, Gardin C, de Botton S, Fenaux P, Kroemer G. Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison. Biochemical Pharmacology. 76: 1417-25. PMID 18617157 DOI: 10.1016/J.Bcp.2008.05.024  0.658
Show low-probability matches.